使用新型财务模型估算任何医院胸外科实践的收入、成本和营业利润率
本研究开发了一种可推广的财务模型,用于估算医院胸外科实践中解剖性肺切除术的付款方特异性报销。
要点
- 模型可计算整体及付款方特异性报销、成本和营业利润率。
- 111例患者接受113次手术,其中肺叶切除102例(90%)。
核心结论
- 该新型财务模型可计算医院胸外科实践整个围手术期的整体及付款方特异性报销、成本和营业利润率,通过调整医院名称、州、业务量和付款方组合,任何项目均可了解其财务贡献并指导投资决策。
研究设计与样本
- 回顾性分析2019年1月至2020年12月就诊于胸外科门诊并最终接受解剖性肺切除术的患者的医疗记录。
- 测量术前和术后检查、门诊就诊和门诊转诊的数量,未捕获门诊转诊后的后续检查或操作。
- 使用疾病诊断相关组、成本收费比、当前操作术语医疗保险支付数据以及私人保险:医疗保险和医疗补助:医疗保险支付比率来估算付款方特异性报销和营业利润率。
主要发现
- 共111例患者符合纳入标准并接受113次手术:肺叶切除102例(90%)、肺段切除7例(6%)、全肺切除4例(4%)。
- 这些患者共接受554项检查、60次转诊至其他专科、626次门诊就诊。
局限性
- 未捕获门诊转诊后的后续检查或操作。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The study objective was to develop a generalizable financial model that estimates payor-specific reimbursements associated with anatomic lung resections for any hospital-based thoracic surgery practice. METHODS: Medical records of patients who presented to the thoracic surgery clinic and eventually underwent an anatomic lung resection from January 2019 to December 2020 were reviewed. The volume of preoperative and postoperative studies, clinic visits, and outpatient referrals was measured. Neither subsequent studies nor procedures from outpatient referrals were captured. Diagnosis-related group, cost-to-charge ratios, Current Procedural Terminology Medicare payment data, and Private:Medicare and Medicaid:Medicare payment ratios were used to estimate payor-specific reimbursements and operating margin. RESULTS: A total of 111 patients met inclusion criteria and underwent 113 operations: 102 (90%) lobectomies, 7 (6%) segmentectomies, and 4 (4%) pneumonectomies. These patients underwent 554 total studies, received 60 referrals to other specialties, and had 626 total clinic visits. The total charges and Medicare reimbursement were $12.5 M and $2.7 M, respectively. After adjusting for a 41% Medicare, 2% Medicaid, and 57% Private payor mix, the total reimbursement was $4.7 M. With a 0.252 cost-to-charge ratio, total costs and operating income were $3.2 M and $1.5 M, respectively (ie, 33% operating margin). Average reimbursement per surgery by payor was $51k for Private, $29k for Medicare, and $23k for Medicaid. CONCLUSIONS: For any hospital-based thoracic surgery practice, this novel financial model can calculate both overall and payor-specific reimbursements, costs, and operating margin across the full perioperative spectrum. By manipulating hospital name, hospital state, volume, and payor mix, any program can gain insights into their financial contributions and use the outputs to guide investment decisions.
引用
- Ashrafi A, Atay SM, Wightman SC, et al. Estimating revenue, costs, and operating margin of any hospital-based thoracic surgery practice using a novel financial model. J Thorac Cardiovasc Surg. 2023. PMID: 36934070. doi:10.1016/j.jtcvs.2023.02.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。